Podcasts about strata decision technology

Tushar Pandey is a distinguished expert in the Life Sciences industry, currently making significant strides at SimBioSys with his innovative approach to healthcare technology. His contributions have been pivotal in advancing medical solutions and improving patient outcomes.   In this episode of the Life Science Success Podcast, host Don interviews Tushar Pandey, CEO and Co-founder of SymBioSys, an innovative company reshaping precision cancer care. Tushar shares his intriguing journey from Uganda to the United States, his transition from engineering to healthcare, and the personal experiences that sparked his passion for precision medicine. The discussion highlights SymBioSys' groundbreaking work in creating digital, cost-effective diagnostics to reduce uncertainty in cancer treatment. They explore the importance of addressing diversity in medical models, harnessing the power of AI, and solving challenges in drug development and patient care. Agendas like the company's comprehensive platform for early-stage breast cancer get a deep dive, showcasing how they bridge imaging, genomics, and patient-centered care for improved outcomes. This conversation is a rich mix of personal narrative, professional insights, and forward-thinking solutions in life sciences.     00:00 Introduction to Life Science Success Podcast 00:34 Sponsor Message from D3 Digital Media Marketing 01:25 Guest Introduction: Tushar Pandey 02:27 Tushar's Background and Journey 04:30 Early Career and Transition to Healthcare 06:01 Strata Decision Technology and Cost Optimization 07:57 Personal Impact of Cancer and Shift to Precision Medicine 08:54 Founding Symbiosis and Mission 11:04 Challenges and Innovations in Cancer Treatment 12:21 Symbiosis' Approach to Precision Medicine 14:04 Scientific and Emotional Theses 15:34 Digital Solutions and Global Scale 15:58 Breast Cancer Treatment and FDA Approval 18:05 Supporting Drug Developers and Dosing Regimens 19:30 Digital Orientation and Multi-Omics Data 20:24 Identifying Critical Data in Precision Medicine 20:50 Incorporating Diversity in Medical Models 23:49 Innovative Projects in Digital Health 25:07 The Role of Imaging in Precision Medicine 31:08 Challenges in Life Sciences and Overcoming Them 33:31 Leadership and Inspiration in Precision Medicine 37:28 Concerns and Future Directions in Healthcare 42:02 Conclusion and Final Thoughts  

In this episode, Laura Dyrda, Vice President, Editor-in-Chief at Becker's Healthcare shares insight into a report from Strata Decision Technology stating that hospital leaders are optimistic about the future despite clear challenges and continued high costs.

Navigating the intricate landscape of inpatient nursing can be a daunting task, especially with the rising wage rates posing significant challenges. It is vital, now more than ever, to implement innovative solutions that not only ensure equitable staffing ratios but also enhance the overall work experience of healthcare professionals. Implementing efficient cost cutting measures and bolstering operational improvements can go a long way in creating an environment that values the contributions of nursing staff, ultimately fostering a more sustainable healthcare ecosystem. Joe Grimaldi, Senior Manager at Strata Decision Technology, introduced: Real-Time Work, to “Highway to Health” at the HFMA 2023. The company's new product is a promising solution that aims to transform the landscape of inpatient nursing units

In this episode, Liz Kirk, SVP of Market Intelligence & Strategic Growth at Strata Decision Technology, discusses value-based care & how it impacts financial planning models.

Host Matt Fisher is joined by Steve Lefar, Chief Strategy Officer, Strata Decision Technology. They discuss Definition of healthcare finance; challenges of determining actual cost of services in healthcare; impact of knowing the cost of care; importance of considering SDOH and other community factors in delivering better care; considerations for driving change in healthcare system. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

In this episode, we're pleased to welcome Steve Lefar, Strata Decision Technology's Chief Strategy Officer, to discuss the cost of healthcare and the many challenges organizations face in terms of reducing healthcare costs.  Learn how to listen to The Hospital Finance Podcast® on your mobile device. Highlights of this episode include: Core challenges organizations face...

Laurie McGraw is speaking with Inspiring Woman Elizabeth Kirk, a senior vice president at Strata Decision Technology.  Liz has spent her career at the intersection of healthcare process automation and optimization to deliver ...

Since the beginning of the pandemic, Dan Michelson has held at least three to five zoom calls per day with hospital CFOs across the country. As the industry navigated the most disruptive and uncertain times in modern history, healthcare leaders turned to Dan for his insight and advice because of the unparalleled visibility he has into the market through his company, Strata Decision Technology. Strata provides financial planning and analytics software for more than 400 health systems and 2,000 hospitals – in other words, about half the U.S. healthcare provider market.While health leaders turn to Dan on an ongoing basis, he's also become known for articles every January that analyze the top trends and topics discussed at the annual J.P. Morgan Healthcare Conference. In fact this year, Dan published two articles – one in Fortune and one in STAT News – and for the third year running, joined Keith Figlioli to dive even deeper with a discussion on the Healthcare is Hard podcast.What surprised both Dan and Keith the most at this year's event is the fact that COVID was not really a focus. CEOs and CFOs from some of the nation's most prominent health systems that presented during JPM's non-profit track barely mentioned it because it's now become a normal part of every health system's operating model. COVID is no longer a specific focus because it's an intrinsic element in everything they do, and they're prepared for it.But Dan's articles touched on some of the other major topics from JPM that he and Keith talk about in this episode, including:Staffing. Staffing. Staffing. The headline of Dan's article in STAT News captured the mood best: “Covid-19 is no longer the biggest issue facing hospitals. Staffing is.” Workforce issues dominated JPM this year and most presenters recognized these issues as their biggest focus and challenge. Dan and Keith discussed how health systems are thinking about staffing differently and how they're thinking about deploying technology differently to ease staffing demands and burnout. They also discussed some of the new challenges providers are facing as the market evolves – such as competition for new talent from virtual care companies, specialty providers, payers and many others – and new strategies for training, recruiting and retention a result.Top strategies for the future. With COVID becoming a normal part of operations, health systems are finally thinking about the future again with a clear eye towards strategy. In Dan's Fortune piece, “The greatest comeback in the history of health care,” he talked about the severe financial strains health systems faced over the past two years, with volumes down 30% to 40% in the early days of the pandemic. But now that the industry has weathered the storm and proven how critical and resilient it is, the focus is the future. From what Dan heard at JPM, he sees strategies falling into five critical areas that he and Keith discussed: M&A, investing in innovation, value-based care, creating destination centers, and deploying virtual care platforms.To hear Dan and Keith talk about these topics and more, listen to this episode of Healthcare is Hard: A Podcast for Insiders.

  In this episode, Dan Michelson, CEO at Strata Decision Technology, will discuss the state of an industry recovering from one of the worst financial crises in the history of healthcare. With a combined network of more than 2,000+ hospitals and 400+ healthcare systems in Strata's network, Dan will share key industry trends from the ongoing National Patient & Procedure Volume Tracker report created by Strata data scientists. He will also share the financial strategies these organizations are adopting on the path to recovery. This episode is sponsored by Strata Decision Technology.  

Dan is the CEO of Strata Decision Technology where his focus is to ensure the company delivers on its mission to help heal healthcare. The company's financial planning, analytics and performance platform is used by over 1,000 healthcare organizations, including many of the largest and most influential healthcare systems in the U.S.  The company has been recognized multiple times as one of the fastest growing companies in the nation by Inc. Magazine, as one of the best places to work in healthcare by Becker's Healthcare and has received the prestigious “Best in KLAS” recognition for the highest customer satisfaction by KLAS Enterprises for the last six years.  Additionally, Dan is a two-time finalist for Illinois Technology CEO of the Year. With close to 30 years of healthcare experience, Dan has been one of the industry's key thought leaders in developing the Decision Support, Financial Planning, Electronic Prescribing and Electronic Health Record markets, including serving on the Certification Commission for Healthcare Information Technology and co-authoring the books Margin + Mission: A Prescription for Curing Healthcare's Cost Crisis and The Electronic Physician. Prior to joining Strata, Dan spent 12 years as part of the leadership team that grew a healthcare software company from 100 to over 6,000 employees. He has provided strategy and process redesign consulting for many of the leading hospitals and health systems in the U.S. and served in leadership roles for Baxter Healthcare and AstraZeneca. Dan is the co-founder of projectMUSIC™, a benefit concert that sends underprivileged children to overnight camp and of HackHunger™, a collaborative of tech companies working to crack the code on hunger.  Dan earned his BS in Finance from Indiana University and his MBA from DePaul University.  He is an avid runner, having completed 17 marathons.

Last year tested nearly every aspect of the healthcare system, making the 2021 J.P. Morgan Health Care Conference like none other in its 39-year history. But there’s at least one constant from the past few years – the insight Dan Michelson, CEO at Strata Decision Technology, offers in the recap he writes for Becker’s Hospital Review.With a customer base that includes 2,000+ hospitals and 400+ healthcare systems, about half of all U.S. healthcare flows through Strata’s financial analytics and performance platform. Needless to say, this gives Dan a unique vantagepoint to observe and add context around the discussions healthcare’s most influential leaders have at JPM every January.Dan’s biggest takeaway this year? While the pandemic stretched providers to the limit – placing extreme demand on care delivery and untold pressures on their financial stability at the same time – the system proved that it’s too vital to fail. But If providers want to be able to say the same thing ten years from now, they’ll have to look and operate much differently than they do today.Just like last year, Dan talked to Keith Figlioli for a special Healthcare is Hard episode where they dissect the ideas from JPM that set the stage for the months and years ahead. They talked about what was lost and gained by holding the event virtually, but more importantly, what they took away that will help health systems – and everyone that supports them – build back stronger. Some of the topics they discussed include:The Mindset for 2021. Everyone thinks the future is hard to predict, but at this point in healthcare, Dan says it really isn’t. Strata has been working with a cohort of about 50 health systems throughout the pandemic to study patient volumes and utilization, publishing findings every two weeks that have become a monitor for the financial and operational impact of Covid-19. Based on the data, he expects volumes in 2021 to remain at their current levels (which are down across the board from 2019) through most of year and begin to pick back up in the fourth quarter. He says the mindset health systems have this year is to “keep it going as best we can” and that 2022 will be the year they expect a return to “normal.” Proving the Payvider Model. As the disconnect between payer and provider continues to cause frustration for consumers, integrated models that align incentives have provided relief, offering a better experience at a lower cost. And the financial stability that integrated systems experienced through the pressures of the pandemic offered another very important proof point for the future of the payvider model. Dan points to Intermountain Healthcare – and former Healthcare is Hard guest Bert Zimmerli – as an example to emulate. The Year of Digitizing Operations. Dan expects to see a very big swing back to managing costs and driving productivity through automation and digitization in 2021. There was no time to worry about cost last year, but as volume remains low and the payer mix impairs profitability, innovation and efficiency are coming back into focus.Following the Money to Home Health. Out of necessity, the pandemic pushed home health and telehealth years ahead of where they would otherwise be. But Dan talks about how health systems won’t maintain their support for home health unless financial incentives align. The speed with which this shift happens will depend largely on CMS taking the lead and putting the right incentives in place.To hear Dan and Keith talk about these topics and more, listen to this episode of Healthcare is Hard.&l

Steve Lefar, Executive Director of Strata Decision Technology, says health systems need to get used to the new normal of lower patient volumes. The company’s recent analysis of hospital data shows patients' behavior has changed, and hospitals can’t count on volumes returning to pre-pandemic levels. 

Today's Guest: Elizabeth Kirk | Senior Vice President of Strategic Services at Strata Decision Technology Greg and Liz talk about the impact of the pandemic on hospital budgets and the budgeting process, the next generation of AI and machine learning products being used to target and eliminate waste and how upcoming regulatory changes in hospital pricing transparency will impact the marketplace. Important Links: Liz' LinkedIn: https://www.linkedin.com/in/elizabeth-stuller-kirk-41519811/ Strata Decision Technology https://www.stratadecision.com/

Dan Michelson is the CEO of Strata Decision Technology, an analytics and financial planning platform that helps over 1,000 leading healthcare organizations and system in the U.S. to figure out and lower their true costs. In this episode, Dan explains why health systems don't understand the true costs of their treatments and operations, the key interests and incentives for doctors and patients to demand reforms, the reasons why Silicon Valley startups have failed to "disrupt" the industry, and the need to understand healthcare on a deeper level. Dan also discusses the impact of coronavirus on hospitals’ bottom lines, the enormous responsibilities that healthcare workers are taking on, his optimism of how we will come out of this crisis stronger, and ways we can get both acknowledge the problems and contribute to the solutions. We would strongly encourage you to follow Strata's campaign and tag #MyHealthcareHero to thank those who are risking their lives for our safety. With close to 30 years of healthcare experience and the mission to "help heal healthcare," Dan has been one of the industry’s key thought leaders in developing the Decision Support, Financial Planning, Electronic Prescribing and Electronic Health Record markets, including serving on the Certification Commission for Healthcare Information Technology and co-authoring the books "Margin + Mission: A Prescription for Curing Healthcare’s Cost Crisis" and "The Electronic Physician."

Steve Lefar with Strata Decision Technology discusses how the COVID-19 pandemic will impact hospital margins. 

Dan Michelson’s recap of the JP Morgan Healthcare Conference in Becker’s Hospital Review has become a must-read over the past few years – whether you attend the conferences or not. Dan’s organization, Strata Decision Technology, works with more than 1,000 hospitals from hundreds of health systems on their financial planning, analytics and performance. And as CEO, he has a unique view across systems that allows him to neatly unpack and bring clarity to the various sessions and conversations that occur throughout the JPM conference.Dan’s insight is especially welcome when it comes to the conversations that happen in the secluded confines of the thirty-second floor of the Westin St. Francis Hotel during JPM week. That’s where dozens of CEOs and CFOs from the nation’s largest health systems gather to hear presentations from their peers about high-level strategies in this rapidly changing market. If you’ve read Dan’s articles and wondered how he got started writing them, or if you’ve wanted to hear directly from him with more context on his thoughts, here is your chance. In this episode of Healthcare is Hard, Keith Figlioli’s conversation with Dan brings his JPM recap to life. This year, based on all the provider presentations and many one-on-one conversations, Dan outlines the 10 questions that health systems should be asking and answering to guide the future of their organizations. He and Keith take a deep dive into these questions, discussing topics including:Performance. Looking at whether a leadership team should spend their time focusing on performance or building a budget is one of the important questions Dan outlines for health systems. He explains the choices systems have in more detail, using OSF Healthcare as an example. The Peoria, Illinois-based provider shifted away from traditional budgeting processes in favor of a rolling approach and according to Dan, saved 20,000 hours of leadership time and more than $1 million in spend.Market share. Dan says providers need to change their mindset and think differently about how they define market share as healthcare evolves. In addition to the “share of cup” analogy Dan explained in his written recap, he talks about his experience hearing Walmart’s head of healthcare discuss the retail behemoth’s view of the market. While providers believe they own the patient relationship, he points out how only half of Americans say they have a primary care provider and among the other half, two-thirds haven’t visited their primary care provider in years. With that data, what does Walmart have to say about the market and the patient-provider relationship? “Alright, we’ll take the other 84%.”The “other five” questions. While Dan’s article framed the ten questions providers should be asking, Keith calls him to task for adding another five at the end of the piece without full explanations. Dan says his point is that the ten specific questions health systems are asking themselves doesn’t really matter; what really matters is that they’re asking tough questions like these at the executive level. However, he explains why he thinks questions about affordability are the ones that leave health systems most exposed right now. To hear Dan and Keith’s conversation, listen to this episode of Healthcare is Hard: A Podcast for Insiders.

David Shelton of PatientMatters talks about how the industry can eliminate surprise bills for good. Rich Daly interviews Paul Anderson from Strata Decision Technology about total cost of care. Also, five ways to engage millennial patients.    Check out this HFMA resource tracking trends and insights on understanding and utilizing total cost of care data:  www.hfma.org/tcoc 

In this episode sponsored by Strata Decision Technology, CEO Dan Michelson talks about the future of value-based care and the joint effort between HFMA and Strata to introduce the industry's first cost accounting adoption model. 

Rich Daly and Chad Mulvany discuss the impact the "public charge" rule will have on hospitals. Jim Zadoorian of ARXchange talks about a new approach to price transparency. Also, Strata Decision Technology provides five ways healthcare organizations can prepare for the future with strategic planning.

Rich Daly interviews Michael Wolford, a senior manager at DHG Healthcare, about the early results of Bundled Payments for Care Improvement Advanced. Also, five reasons why health systems will need advanced cost accounting in a segment sponsored by Strata Decision Technology.

Justin’s guest is Dan Michelson (@DMfuel), CEO of Strata Decision Technology (@StrataDecision) discussing how decisions drive healthcare and better information can lead to better decisions. Additionally, revenue cycle performance.     The post Dan Michelson with Strata Decision Technology appeared first on Business RadioX ®.

021012 Boney

Like it or not, the Affordable Care Act – dubbed Obamacare by detractors and supporters alike – will become the law of the land in the United States in less than a year. How are hospitals beginning to cope with important data management requirements? How are healthcare analytics professionals guiding hospital administrators as they prepare for a brave new future? Listen to former INFORMS President President Don Kleinmuntz of Strata Decision Technology explore the growing role of analytics and hospital management in this broad-ranging interview recorded at the 2013 INFORMS Conference on Business Analytics.